Introduction

This is the 1st cardiovascular pharmacotherapy symposium organized by pharmacy department in Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.  The symposium aims to further the understanding of cardiovascular pharmacotherapy and to foster discussion about the application of its knowledge to patient care. The symposium is designed to bring together clinicians with interests in the application of clinical pharmacy in cardiovascular pharmacotherapy. The symposium will be particularly focusing on the pharmacotherapy and its applications in cardiovascular diseases. Cutting edge evidence-based medicine will be presented, ranging from the pharmacotherapy of percutaneous coronary intervention, to management of acute coronary syndrome, hypertension, atrial fibrillation, venous thromboembolism, heart failure, and critical clinical pathways relevant to the pathophysiology and treatment of cardiovascular diseases. In addition, the meeting will be specifically structured to focus on novel targets regulating cardiovascular diseases progression and specific targets with therapeutic potential. In line with this goal, specific sessions include ones designed to highlight new evidence in the management of cardiovascular diseases, advances in prevention and risk factors modification, and updates on ongoing clinical trials. Advances in understanding mechanisms underlying cardiovascular diseases will also be addressed, and will be focused on taking knowledge gained in this arena and applying it to their managements. The conference will last 2 days and is designed to appeal to a broad audience of Cardiovascular Physicians, Clinical Pharmacists, Pharmacists, Nurses, Technicians, Others interested in cardiovascular Pharmacotherapy and other relevant health care professionals, promoting interaction among participants from diverse disciplines through lectures, discussions, workshops, and informal interactions. We expect an exciting exchange of ideas, new collaborations to be initiated, and a greater understanding of the most promising treatment strategies that could alter our approach to patients with cardiovascular diseases.